- Dr Del Trezise Appointed Chair of ELRIG
- Xeltis Successfully Passes Evaluation Phase for €10Mil Investment from European Innovation Council
- BDD Pharma Opens Brand New GMP Manufacturing Facility Following £2m In Funding
- Quibim Announces New Board of Directors To Promote Growth And Strategic Expansion
- Hello Heart Unveils Connected Pill Box to Radically Improve Medication Adherence
- How Health Systems Can Mitigate the Impact of Tariffs or Hospital Supply Chain Disruptions | By Kelley Jacobsen, Sr VP, Supply Chain & Shared Services, TRIMEDX
- U.S. FDA Grants Paige Breakthrough Device Designation for AI Application that Detects Cancer Across Different Anatomic Sites
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
Inspira Technologies Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
Dagi-Ben Noon, CEO of Inspira Technologies, reflects on the partnership’s significance: “By Integrating our technology to oxygenate blood directly with Ennocure’s infection prevention solutions, we are focusing on potentially improving patient outcomes in ICUs and paving the way for safer, more effective life-support treatments. This collaboration is expected to accelerate the development and broaden the implementation of our advanced technology.”
MolecuLight Reports United States Patent and Trademark Office Cancels All Claims of Swift Medical’s Patent
The decision cancels each of the original claims of the ‘345 Patent and declares unpatentable each of Swift’s proposed substitute claims. Amongst the prior art deemed by the USPTO to render the ‘345 Patent unpatentable is a patent application licensed to MolecuLight that lists MolecuLight’s Founder, Dr. Ralph DaCosta, as the sole inventor.
Kaleido Launches Cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for People with Diabetes
It combines the convenience of the Kaleido insulin pump with two market-leading innovations designed by Diabeloop and Dexcom to create a Hybrid Closed Loop system for managing type 1 diabetes which is flexible, self-learning and easy to use.
Biocomposites Expands Product Portfolio | Launches SYNICEM Spacers in the UK
SYNICEM spacers are antibiotic-loaded, preformed spacers which overcome the challenges of traditional intra-operative moulded and handmade spacers. They help support surgeons’ revisions of the hip, knee and shoulder by preserving articular space and aiding the treatment of infection.
Clinical Trials
Salubris Biotherapeutics Presents Positive 6-Month Data from Phase 1b Clinical Trial of JK07 in Late-Breaking Session at The Heart Failure Society of America Annual Meeting 2023
The data were presented in a late breaking oral session during the Heart Failure Society of America Annual Scientific Meeting 2023. JK07 is the first investigational antibody fusion protein and first selective ErbB4 agonist to enter clinical development for heart failure. Heart failure is a leading cause of morbidity and mortality globally, with estimates of more than 6 million patients affected by HFrEF and HFpEF in the US.
Neoadjuvant Study with LTX-315 In Early-stage Melanoma Patients to be Presented at the 15th Nordic Melanoma Meeting
The title of the presentation is: Neoadjuvant LTX-315 in combination with pembrolizumab in resectable stage III/IV melanoma (NeoLIPA trial): Protocol for a single center phase II open label study.
Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System
This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection.
Biotechnology News
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Digital Pathology Reaches an Inflection Point as AI Targets Workflow Gaps | By Yair Rivenson, PhD Founder and CEO, Pictor Labs
Laboratories face mounting pressure to modernize imaging, preserve tissue, and reduce sequencing failures as adoption continues to move at a glacial pace
FIZE Medical Launches 5,000-Patient Retrospective Study to Further Establish the benefits of using FIZE kUO in managing ICU patients’ Hemodynamic status
By continuously capturing renal function patterns, the study aims to demonstrate how FIZE kUO® can provide data for early signs of instability that are often missed by intermittent measurements
Skin May Become the First Organ to Fulfill the Promise of Regenerative Medicine | By Dr. Ned Swanson – President & Chief Medical Officer of PolarityBio
The field of regenerative medicine may be on the cusp of an evolution, and due to the unique attributes of skin and wounds, the largest organ in the body may be emerging as a leader
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Inomagen Therapeutics Awarded $1.6 million NIH SBIR Phase 2 Grant
Proceeds from the award will be utilized to continue the advancement of the company’s novel gene therapy for the treatment of atrial fibrillation (AF), the world’s most common arrythmia.
Bluegrass Vascular Closes $5 Mil Convertible Debt Financing
Funding will support the acceleration of the commercial expansion of Bluegrass Vascular’s Surfacer® System.
Ceros Financial Services Arranges $15MM Financing for Pristine Surgical
“Pristine Surgical has brought the endoscope into the 21st Century, improving the endoscopic procedure for both patient and surgeon,” said Mark Goldwasser, CEO of Ceros Financial Services.
Saluda Medical Announces $125M Equity Financing
Net proceeds from the financing will be used to operationalize and scale commercialization of the Evoke® Spinal Cord Simulation System (SCS) for chronic pain.
Market Reports
Advancements in Imaging
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare - Understanding the Business Side of the Industry and Its Implications
Helpful Tips For Picking Medical Equipment For Your Business
Read this article now and learn how to pick out medical equipment for your start-up!
How Can SAST Be So Much Useful?
Software development could easily open up the door to cybercriminals. This is why applications must contend with a constant barrage of malicious activity from bots
Equipment That Will Improve The Quality Of Your Healthcare Services
Providing quality healthcare services is important for any medical practice. Whether you are a doctor, nurse, or other health care professional, having the right equipment
How Healthcare Providers Can Embrace A Data-Centric Approach
Data is an integral part of business operations in all verticals, and healthcare is no exception. Leveraging patient information helps hospitals and clinics to provide